US Announces Anti-Malarial Drug Trial Against COVID-19 In Detroit Hospital
WASHINGTON, April 6 — The antimalarial drug hydroxychloroquine will be used in a trial covering 3,000 patients at a hospital in Detroit, Michigan, and the results will be tracked in…